A Dose Range Finding Study to Evaluate the Efficacy and Safety of AZD9668 Administered Orally at Three Dose Levels to Patients With Chronic Obstructive Pulmonary Disease (COPD) on Treatment With Tiotropium
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
40–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of COPD with symptoms over 1 year
Smokers or ex-smokers
Males or post-menopausal females between 40 and 80 years old
Able to use electronic devices
You may not be if
Past history or current evidence of clinically significant heart disease
Current diagnosis of asthma
Patients who require long term oxygen therapy
Treatment with antibiotics within 4 weeks of study visit 1b
Clareo Health | A Dose Range Finding Study to Evaluate the Efficacy and Safety of AZD9668 Administered Orally at Three Dose Levels to Patients With Chronic Obstructive Pulmonary Disease (COPD) on Treatment With Tiotropium
